Survival analysis of CTHRC1 and SPP1 gene expression in PAAD demonstrated that patients with high expression of these genes led to worse survival (Fig. 5c), demonstrating the pro-tumor functions of these genes in the clinical context. This evidence concerns the gene SPP1 and pancreatic adenocarcinoma.